Meditation Clinical Trial
Official title:
Feasibility of Using a Mobile App (i.e., Calm) to Decrease Overall Stress in Middle-aged (i.e., 40-64 Years) Men and Women Who Report High Stress (>15 on PSS)
Verified date | February 2022 |
Source | Arizona State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine the preliminary effects of using a mobile app (i.e., Calm) to decrease overall stress in middle-aged (i.e., 40-64 years) men and women who report high stress (greater than 15 on PSS). The study design is a randomized control trial with baseline, post-intervention (4 weeks from baseline), and follow-up phone interview (5 weeks from baseline) assessments. Middle-aged adults will be randomized to either a Calm meditation Intervention group or an attention control podcast group. Participants will be randomized after the completion of baseline and informed consent. Specific aim 1: Determine the feasibility (acceptability, demand) of using CALM app at least 10 min/day to reduce stress (greater than 15 on Perceived Stress Scale [PSS]) in middle-aged men and women. Benchmarks for feasibility: (acceptability) Recruitment greater than 40 percent men; greater than 75 percent satisfied with intervention; 75 percent perceive daily meditation and app components as appropriate and useful; (demand) Retention of men greater than 75 percent; greater than 80 percent adherence (minutes/week) to the meditation intervention. Specific aim 2: Explore the preliminary effect of meditation using Calm on overall perceived stress as compared to the health education group. Specific aim 3: Explore the preliminary effect of meditation using Calm on anxiety and depression. Specific aim 4: Explore gender as a moderator of the effect of meditation using Calm on stress. Specific aim 5: Explore the mediators of mindfulness, physical activity, eating, and coping behaviors on stress, anxiety and depression using Calm for meditation.
Status | Completed |
Enrollment | 83 |
Est. completion date | June 16, 2020 |
Est. primary completion date | May 18, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 64 Years |
Eligibility | Inclusion Criteria: - Men or Women - Age 40-64 - Able to read/understand English - Have access to a smartphone on a daily basis - A score of 15 or higher on the Perceived Stress Scale (PSS) - Willing to be randomized - Willing to download a mobile application Exclusion Criteria: - Have consistently practiced mindfulness meditation within the last 12 months - Currently using the Calm app or another meditation app - Currently prescribed mental health or mood medication - Low levels of stress (i.e., less than a score of 15 assessed with the Perceived Stress Scale) - Currently reside outside the United States |
Country | Name | City | State |
---|---|---|---|
United States | Arizona Biomedical Collaborative | Phoenix | Arizona |
Lead Sponsor | Collaborator |
---|---|
Arizona State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility: Acceptability | Acceptability will be measured using a satisfaction survey at the end of the study, following all other measures (satisfied with the intervention and perceive daily meditation and app components as appropriate and useful) | Measured 1x at post-intervention about experience in study, about 4 weeks. | |
Primary | Feasibility: Demand | Demand will be measured using the subjective usage data (weekly participation logs measuring adherence (minutes/week) and the objective app usage data (data collected by the app measuring adherence (minutes/week) to the meditation intervention). | 1x at post-intervention about participation time in study (4 weeks total) | |
Secondary | Stress | Stress will be measured using the Perceived Stress Scale -10 item, with scores ranging from 10-40) and a higher score indicates a worse outcome. | Change from baseline (week 0) to post-intervention (week 4) | |
Secondary | Anxiety | Anxiety will be measured using the Hospital Anxiety and Depression Scale, with scores ranging from 0-21, and a higher score indicates a worse outcome. | Change from baseline (week 0) to post-intervention (week 4) | |
Secondary | Depression | Depression will be measured using the Hospital Anxiety and Depression Scale, with scores ranging from 0-21, and a higher score indicates a worse outcome. | Change from baseline (week 0) to post-intervention (week 4) | |
Secondary | Gender as moderator of stress | Self-reported gender | Change from baseline (week 0) to post-intervention (week 4) | |
Secondary | Mindfulness as a mediator of stress | Mindfulness will be measured using the Mindful Attention Awareness Scale, with scores ranging from 15-90, and a higher score indicates a better outcome. | Change from baseline (week 0) to post-intervention (week 4) | |
Secondary | Physical Activity as a mediator on stress, anxiety, and depression | Physical activity will be measured using the International Physical Activity Questionnaire, when a higher score indicates a better outcome. | Change from baseline (week 0) to post-intervention (week 4) | |
Secondary | Eating as a mediator on stress, anxiety, and depression | Eating will be measured using the Salzburg Stress Eating Scale, with scores ranging from 5-100, and a higher score indicates a worse outcome. | Change from baseline (week 0) to post-intervention (week 4) | |
Secondary | Coping behaviors as a mediator on stress, anxiety, and depression | Coping behaviors will be measured using the Brief COPE Inventory, with scores ranging from 2-8, and a higher score indicates a better outcome. | Change from baseline (week 0) to post-intervention (week 4) | |
Secondary | Resilience | Resilience will be measured using the Brief Resilience Scale, with scores ranging from 1-5, and a higher score indicates a better outcome. | Change from baseline (week 0) to post-intervention (week 4) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02157766 -
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
|
N/A | |
Recruiting |
NCT05020301 -
Investigation of Functional Brain Network in Altered Meditation State With Multimodal Neuroimaging
|
N/A | |
Completed |
NCT04917081 -
'Go With the Flow': Effects of Mindful Self-Compassion in Psychiatric Rehabilitation
|
N/A | |
Recruiting |
NCT05645835 -
Dynamic Neural Systems Underlying Social-emotional Functions in Older Adults
|
N/A | |
Completed |
NCT03257007 -
Mindfulness to Enhance Quality of Life and Support Advance Care Planning
|
N/A | |
Completed |
NCT03459690 -
EEG Changes With Guided Online Meditation
|
N/A | |
Not yet recruiting |
NCT05314166 -
Impact of Face-to-face Meditation on Non-attachment to Self and Identity Threat
|
N/A | |
Recruiting |
NCT04968795 -
Heartfulness Meditation and Corporate Burnout
|
||
Recruiting |
NCT05285488 -
Impact of Distance Meditation on Non-attachment to the Self and Identity Threat
|
N/A | |
Completed |
NCT05619419 -
Study of Affect Induction for Lab Induced Pain in Healthy Undergraduates
|
N/A | |
Completed |
NCT04302623 -
Meditation and Yoga for Irritable Bowel Syndrome
|
N/A | |
Completed |
NCT05669066 -
Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement
|
N/A | |
Completed |
NCT04557033 -
My Mindful Moments: A Mindfulness Meditation and Digital Art Activity
|
N/A | |
Recruiting |
NCT05455814 -
Brain Health With Inner Engineering Meditation
|
N/A | |
Completed |
NCT06424951 -
Kindness is Lesser Preferable Than Happiness: Investigating Interest in Different Effects of the Loving-kindness and Compassion Meditations
|
N/A | |
Suspended |
NCT02104349 -
Mindfulness Meditation for Spine Surgery Pain
|
N/A | |
Completed |
NCT04632875 -
Online Trial of Meditation and Behavior
|
N/A | |
Completed |
NCT02578433 -
Mindful Self Compassion in Rehabilitation Inpatients
|
N/A | |
Completed |
NCT02313779 -
Meditation and Decision Making Study III
|
N/A | |
Completed |
NCT05154565 -
Effect of a Daily Meditation Intervention in Student Pharmacists
|
N/A |